- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DBV Technologies (DBVT)
DBV Technologies stock price live, this page displays NASDAQ DBVT stock exchange data. View the DBVT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the DBV Technologies real time stock price chart below.
What Is the DBV Technologies Stock Price Today?
The DBV Technologies stock price today is 20.630.
What Is the Stock Symbol for DBV Technologies?
The stock symbol for DBV Technologies is "DBVT."
What Stock Exchange Does DBV Technologies Trade On?
DBV Technologies is listed and trades on the NASDAQ stock exchange.
Is DBV Technologies a Good Stock to Buy?
Determining whether DBV Technologies—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DBVT quote. (ISIN: US23306J3095)
What Is the DBV Technologies Stock Price Today?
The DBV Technologies stock price today is 20.630.
What Is the Stock Symbol for DBV Technologies?
The stock symbol for DBV Technologies is "DBVT."
What Stock Exchange Does DBV Technologies Trade On?
DBV Technologies is listed and trades on the NASDAQ stock exchange.
Is DBV Technologies a Good Stock to Buy?
Determining whether DBV Technologies—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DBVT quote. (ISIN: US23306J3095)
20.630
-0.770(-3.60%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.600
21.235
52 wk Range
6.830
26.185
DBVT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.60021.235
52 wk Range
6.83026.185
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DBVT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
40.186
Upside
+94.79%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
- DBV Technologies receives Investment Bank Analyst Rating Update
- Investing.com
Pro - DBV Technologies receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- DBV Technologies receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis. The company’s earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
DBV Technologies SWOT Analysis
Allergy Innovation | Explore DBV Technologies' groundbreaking Viaskin Peanut patch, offering a non-invasive solution for peanut allergies in children with promising clinical results |
Market Potential | Delve into the projected $2 billion annual peak sales for Viaskin Peanut, driven by strong physician intent and a growing patient base |
Financial Outlook | Learn about DBV's improved financial position, with $128 million in cash and potential for $180 million more, despite current cash burn concerns |
Analyst Perspectives | Discover varied analyst price targets ranging from $10 to $21, reflecting optimism about DBV's future prospects in the allergy treatment market |
DBV Technologies Earnings Call Summary for Q2/2024
- DBV Technologies advances Viaskin Peanut trials; VITESSE Phase 3 enrollment for ages 4-7 to complete by Q3 end
- Net loss of $60.5M in H1 2024; cash runway extended to Q1 2025 through cost-saving measures
- FDA feedback pending on labeling approach for toddlers aged 1-3; EPITOPE trial year 3 results expected later in 2024
- Operating expenses at $65M, including $24M non-recurring costs; cash used in operations totaled $70M
- Company optimistic about FDA agreement on labeling; emphasizes patient experience data importance
Last Updated: 2024/08/01, 00:54
Read Full TranscriptCompare DBVT to Peers and Sector
Metrics to compare | DBVT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDBVTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.8x | −2.9x | −0.4x | |
PEG Ratio | −0.77 | 0.19 | 0.00 | |
Price/Book | 6.8x | 3.2x | 2.6x | |
Price / LTM Sales | 202.4x | 3.9x | 3.2x | |
Upside (Analyst Target) | 120.7% | 56.1% | 50.6% | |
Fair Value Upside | Unlock | 11.5% | 6.6% | Unlock |
Analyst Ratings
5 Buy
0 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 40.186
(+94.79% Upside)
Earnings
Latest Release
Mar 26, 2026
EPS / Forecast
-0,24 / --
Revenue / Forecast
645K / --
FAQ
What Is the DBV Technologies (DBVT) Stock Price Today?
The DBV Technologies stock price today is 20,630 USD.
What Stock Exchange Does DBV Technologies Trade On?
DBV Technologies is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for DBV Technologies?
The stock symbol for DBV Technologies is "DBVT."
What Is the DBV Technologies Market Cap?
As of today, DBV Technologies market cap is 1,150B USD.
What Is DBV Technologies's Earnings Per Share (TTM)?
The DBV Technologies EPS (TTM) is -1,053.
From a Technical Analysis Perspective, Is DBVT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has DBV Technologies Stock Split?
DBV Technologies has split 2 times.
How Many Employees Does DBV Technologies Have?
DBV Technologies has 117 employees.
What is the current trading status of DBV Technologies (DBVT)?
As of Apr 10, 2026, DBV Technologies (DBVT) is trading at a price of 20,630 USD, with a previous close of 21,400 USD. The stock has fluctuated within a day range of 20,600 USD to 21,235 USD, while its 52-week range spans from 6,830 USD to 26,185 USD.
What Is DBV Technologies (DBVT) Price Target According to Analysts?
The average 12-month price target for DBV Technologies is 40,186 USD, with a high estimate of 51.74517826 USD and a low estimate of 5.80829924 USD. 5 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +94,79% Upside potential.
What Is the DBVT Premarket Price?
DBVT's last pre-market stock price is 20,830 USD. The pre-market share volume is 2 920,000, and the stock has decreased by -0,570, or -2,660%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.